The Coronavirus Disease 2019 (COVID‐19) pandemic have now becoming a worldwide catastrophe, as of September 9, 2020, the conformed COVID‐19 cases are 27,486,960, and 894,983 deaths are reported.1 Varicella (chickenpox), rubella and measles are also infectious diseases caused by the respiratory virus. We have noticed that the reported varicella cases, rubella cases, and measles cases in Guangzhou City

Glatiramer acetate (GA; trade name: Copaxone®) is a mixture of synthetic polypeptides that is used for the immunomodulatory treatment of relapsing‐remitting multiple sclerosis (RRMS).1 While some mechanisms of action of GA are still not completely understood, it has been shown to bind to major histocompatibility complex molecules and to induce an in vivo change of the cytokine secretion pattern of

The purpose is a comparative study of the cellular reactions in capillary and venous blood in northerners under general hypothermia in a climatic chamber during different photoperiods. The authors examined 108 relatively healthy people (80 women and 28 men aged 21‐ to 50‐years old).

Protein neddylation, one of the most important posttranslational modifications that tagging neuronal precursor cell‐expressed developmentally downregulated protein 8 onto substrate proteins, plays fundamental roles in the process of many cellular functions. A number of studies have demonstrated the critical roles of neddylation modification in multiple pathophysiological processes, but its regulatory

The 2019 novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]) is driving a novel atypical pneumonia (coronavirus disease 2019 [COVID‐19]) outbreak in Wuhan, causing huge public health challenges both in China and globally. Limited data are available for information and prognosis on COVID‐19 patients with pre‐existing chronic kidney disease.

Chronic asthma is a heterogeneous disease, and increased eosinophils have been shown to predict increased asthma exacerbations, especially in adults. Recent recommendations suggest the need for supplemental PPV‐23 vaccination in older children with chronic asthma.